Aroa Biosurgery Limited

ASX:ARX 株式レポート

時価総額:AU$224.2m

Aroa Biosurgery マネジメント

マネジメント 基準チェック /34

現在、CEO に関する十分な情報がありません。

主要情報

Brian Ward

最高経営責任者

NZ$1.1m

報酬総額

CEO給与比率54.1%
CEO在任期間17.2yrs
CEOの所有権9.6%
経営陣の平均在職期間3.6yrs
取締役会の平均在任期間9.8yrs

経営陣の近況

Recent updates

We're Not Worried About Aroa Biosurgery's (ASX:ARX) Cash Burn

Nov 13
We're Not Worried About Aroa Biosurgery's (ASX:ARX) Cash Burn

Take Care Before Jumping Onto Aroa Biosurgery Limited (ASX:ARX) Even Though It's 29% Cheaper

Aug 22
Take Care Before Jumping Onto Aroa Biosurgery Limited (ASX:ARX) Even Though It's 29% Cheaper

Investors Aren't Entirely Convinced By Aroa Biosurgery Limited's (ASX:ARX) Revenues

Jun 12
Investors Aren't Entirely Convinced By Aroa Biosurgery Limited's (ASX:ARX) Revenues

Here's Why We're Not At All Concerned With Aroa Biosurgery's (ASX:ARX) Cash Burn Situation

Mar 25
Here's Why We're Not At All Concerned With Aroa Biosurgery's (ASX:ARX) Cash Burn Situation

Why Investors Shouldn't Be Surprised By Aroa Biosurgery Limited's (ASX:ARX) 25% Share Price Plunge

Jan 30
Why Investors Shouldn't Be Surprised By Aroa Biosurgery Limited's (ASX:ARX) 25% Share Price Plunge

Aroa Biosurgery Limited's (ASX:ARX) Revenues Are Not Doing Enough For Some Investors

Nov 14
Aroa Biosurgery Limited's (ASX:ARX) Revenues Are Not Doing Enough For Some Investors

Industry Analysts Just Made A Captivating Upgrade To Their Aroa Biosurgery Limited (ASX:ARX) Revenue Forecasts

Nov 02
Industry Analysts Just Made A Captivating Upgrade To Their Aroa Biosurgery Limited (ASX:ARX) Revenue Forecasts

Aroa Biosurgery Limited's (ASX:ARX) Intrinsic Value Is Potentially 50% Above Its Share Price

Oct 25
Aroa Biosurgery Limited's (ASX:ARX) Intrinsic Value Is Potentially 50% Above Its Share Price

We Think Aroa Biosurgery (ASX:ARX) Can Easily Afford To Drive Business Growth

May 13
We Think Aroa Biosurgery (ASX:ARX) Can Easily Afford To Drive Business Growth

Here's What Analysts Are Forecasting For Aroa Biosurgery Limited (ASX:ARX) After Its Annual Results

May 26
Here's What Analysts Are Forecasting For Aroa Biosurgery Limited (ASX:ARX) After Its Annual Results

An Intrinsic Calculation For Aroa Biosurgery Limited (ASX:ARX) Suggests It's 27% Undervalued

Mar 22
An Intrinsic Calculation For Aroa Biosurgery Limited (ASX:ARX) Suggests It's 27% Undervalued

Do Institutions Own Aroa Biosurgery Limited (ASX:ARX) Shares?

Feb 24
Do Institutions Own Aroa Biosurgery Limited (ASX:ARX) Shares?

Don't Ignore The Fact That This Insider Just Sold Some Shares In Aroa Biosurgery Limited (ASX:ARX)

Feb 24
Don't Ignore The Fact That This Insider Just Sold Some Shares In Aroa Biosurgery Limited (ASX:ARX)

Aroa Biosurgery Limited's (ASX:ARX) Intrinsic Value Is Potentially 44% Above Its Share Price

Dec 16
Aroa Biosurgery Limited's (ASX:ARX) Intrinsic Value Is Potentially 44% Above Its Share Price

CEO報酬分析

Aroa Biosurgery の収益と比較して、Brian Ward の報酬はどのように変化したか?
日付総報酬給与会社業績
Mar 31 2024NZ$1mNZ$583k

-NZ$11m

Dec 31 2023n/an/a

-NZ$9m

Sep 30 2023n/an/a

-NZ$8m

Jun 30 2023n/an/a

-NZ$4m

Mar 31 2023NZ$1mNZ$552k

-NZ$396k

Dec 31 2022n/an/a

-NZ$1m

Sep 30 2022n/an/a

-NZ$2m

Jun 30 2022n/an/a

-NZ$5m

Mar 31 2022NZ$1mNZ$542k

-NZ$8m

Dec 31 2021n/an/a

-NZ$10m

Sep 30 2021n/an/a

-NZ$11m

Jun 30 2021n/an/a

-NZ$15m

Mar 31 2021NZ$2mNZ$483k

-NZ$19m

報酬と市場: Brianの 総報酬 ($USD 633.03K ) は、 Australian市場 ($USD 298.50K ) の同規模の企業の平均を上回っています。

報酬と収益: Brianの報酬は、過去 1 年間の会社の業績と一致しています。


CEO(最高経営責任者

Brian Ward

17.2yrs

在職期間

NZ$1,078,619

報酬

Dr. Brian Ward, B.V.Sc, MBA(dist) has been Executive Director at Aroa Biosurgery Limited since September 21, 2007 and serves as its Managing Director and Chief Executive Officer. He has founded Aroa Biosur...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Brian Ward
Founderno dataNZ$1.08m9.6%
A$ 21.5m
James Agnew
CFO & Joint Company Secretary4.8yrsNZ$627.01kデータなし
Rod Stanley
Chief Technology Officerless than a yearデータなしデータなし
Barnaby May
Chief Scientific Officer2.9yrsデータなし0.95%
A$ 2.1m
Neetha Alex-Kumar
General Counselno dataデータなしデータなし
Frazer Murray
Director of Global Marketing & Strategyno dataデータなしデータなし
Yasmin Winchester
Vice President of Qualityno dataデータなしデータなし
Tracy Weimar
Joint Company Secretary4.3yrsデータなしデータなし
Adam Young
Vice President of Medical Affairsno dataデータなしデータなし

3.6yrs

平均在職期間

経験豊富な経営陣: ARXの経営陣は 経験豊富 であると考えられます ( 3.6年の平均在職年数)。


取締役

名称ポジション在職期間報酬所有権
Brian Ward
Founder17.2yrsNZ$1.08m9.6%
A$ 21.5m
James McLean
Independent Non-Executive Chairperson13.3yrsNZ$212.19k0.82%
A$ 1.8m
John Diddams
Independent Non-Executive Director5yrsNZ$159.36k0.35%
A$ 775.2k
John Pinion
Independent Non-Executive Director9.8yrsNZ$187.52k0.14%
A$ 307.1k
Philip McCaw
Non-Executive Director16.7yrsNZ$130.68k5.68%
A$ 12.7m
Catherine Mohr
Independent Non-Executive Director2yrsNZ$178.02k0.13%
A$ 283.6k
Darla Hutton
Independent Non-Executive Directorless than a yearNZ$4.73k0.041%
A$ 91.1k

9.8yrs

平均在職期間

58yo

平均年齢

経験豊富なボード: ARXの 取締役会経験豊富 であると考えられます ( 9.8年の平均在任期間)。